[1] BIN P, TANG Z Y, LIU S J, et al. Intestinal microbiota mediates enterotoxigenic Escherichia coli-induced diarrhea in piglets[J]. BMC Vet Res, 2018, 14(1):385. [2] BOECKMAN J X, SPRAYBERRY S, KORN A M, et al. Effect of chronic and acute enterotoxigenic E. coli challenge on growth performance, intestinal inflammation, microbiome, and metabolome of weaned piglets[J]. Sci Rep, 2022, 12(1):5024. [3] JENSEN J, LARSEN M M, BAK J. National monitoring study in Denmark finds increased and critical levels of copper and zinc in arable soils fertilized with pig slurry[J]. Environ Pollut, 2016, 214:334-340. [4] CIESINSKI L, GUENTHER S, PIEPER R, et al. High dietary zinc feeding promotes persistence of multi-resistant E. coli in the swine gut[J]. PLoS One, 2018, 13(1):e0191660. [5] 贺培益, 王 米, 孟新宇, 等. 中药治疗早期断奶仔猪腹泻研究进展[J]. 中兽医医药杂志, 2009, 28(2):23-25. HE P Y, WANG M, MENG X Y, et al. Advances in traditional Chinese medicines against early-weaned piglet diarrhea[J]. Journal of Traditional Chinese Veterinary Medicine, 2009, 28(2):23-25.(in Chinese) [6] 鲁祖汉. 猪腹泻症的中兽医辨证施治[J]. 中国兽医杂志, 2015, 51(3):58-61. LU Z H. Chinese veterinary diagnosis and treatment of porcine diarrhoeal[J]. Chinese Journal of Veterinary Medicine, 2015, 51(3):58-61.(in Chinese) [7] 周恩慧, 许二平, 张 楠, 等. 香砂六君子汤防治胃癌的临床与实验研究进展[J]. 中国实验方剂学杂志, 2023, 29(4):221-227. ZHOU E H, XU E P, ZHANG N, et al. Xiangsha Liu Junzitang for prevention and treatment of gastric cancer:a review[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2023, 29(4):221-227.(in Chinese) [8] 刘梦雅, 成映霞, 白 敏, 等. 香砂六君子汤对脾胃虚弱型功能性消化不良大鼠的干预机制研究[J]. 中国实验动物学报, 2023, 31(2):232-239. LIU M Y, CHENG Y X, BAI M, et al. Mechanism of Xiangsha Liujunzi Tang intervention for functional dyspepsia rats with spleen and stomach weakness through the CaM/MLCK/MLC20 pathway[J]. Acta Laboratorium Animalis Scientia Sinica, 2023, 31(2):232-239.(in Chinese) [9] 李淑红, 刘华一, 唐艳萍. 香砂六君子汤联合四联疗法治疗幽门螺杆菌感染致脾胃虚弱型消化性溃疡48例临床观察[J]. 中医杂志, 2016, 57(21):1854-1857, 1863. LI S H, LIU H Y, TANG Y P, et al. Clinical observation on 48 cases of peptic ulcer of spleen and stomach deficiency type caused by helicobacter pylori infection treated by Xiangsha Liujunzi Decoctioncombined with quadruple therapy[J]. Journal of Traditional Chinese Medicine, 2016, 57(21):1854-1857, 1863.(in Chinese) [10] 马 艳, 毛志田. 香砂六君子汤联合西药治疗HP阳性脾胃虚弱型消化性溃疡临床研究[J]. 陕西中医, 2020, 41(3):357-359. MA Y, MAO Z T. Clinical study of Xiangsha Liujunzi decoction combined with western medicine in the treatment of HP positive peptic ulcer[J]. Shaanxi Journal of Traditional Chinese Medicine, 2020, 41(3):357-359.(in Chinese) [11] 洪文文. 香砂六君子汤对进展期胃癌化疗患者免疫功能的影响[D]. 南京:南京中医药大学, 2018. HONG W W. The effect of Xiang-Sha-Liu-Jun-Zi-Tang on immune function of patients with advanced gastric cancer[D]. Nanjing:Nanjing University of Chinese Medicine, 2018.(in Chinese) [12] 张 翥, 王明周, 朱 燕, 等. 香砂六君子汤对产肠毒素性大肠杆菌诱导断奶腹泻仔猪的腹泻指数、生长性能和小肠黏膜发育的影响[J]. 中国畜牧杂志, 2021, 57(8):242-245. ZHANG Z, WANG M Z, ZHU Y, et al. Effects of Xiangsha Liujunzi decoction on diarrhoea index, growth performance and small intestinal mucosa development of piglets with enterotoxigenic Escherichia coli induced weaning diarrhoea[J]. Chinese Journal of Animal Science, 2021, 57(8):242-245.(in Chinese) [13] MADEC F, BRIDOUX N, BOUNAIX S, et al. Experimental models of porcine post-weaning colibacillosis and their relationship to post-weaning diarrhoea and digestive disorders as encountered in the field[J]. Vet Microbiol, 2000, 72(3-4):295-310. [14] KIM K, SONG M, LIU Y H, et al. Enterotoxigenic Escherichia coli infection of weaned pigs:intestinal challenges and nutritional intervention to enhance disease resistance[J]. Front Immunol, 2022, 13:885253. [15] 黄国文, 张若凡, 叶艳新, 等. 琥珀酸对产肠毒素大肠杆菌K88感染小鼠肠道炎症的影响及其机制研究[J]. 动物营养学报, 2022, 34(8):5384-5392. HUANG G W, ZHANG R F, YE Y X, et al. Effects of succinic acid on intestinal inflammation of mice infected with enterotoxigenic Escherichia coli K88 and its mechanism[J]. Chinese Journal of Animal Nutrition, 2022, 34(8):5384-5392.(in Chinese) [16] MOOR A E, HARNIK Y, BEN-MOSHE S, et al. Spatial reconstruction of single enterocytes uncovers broad zonation along the intestinal villus axis[J]. Cell, 2018, 175(4):1156-1167. e15. [17] XU C L, YAN S Q, GUO Y, et al. Lactobacillus casei ATCC 393 alleviates enterotoxigenic Escherichia coli K88-induced intestinal barrier dysfunction via TLRs/mast cells pathway[J]. Life Sci, 2020, 244:117281. [18] BRUBAKER J, ZHANG X Y, BOURGEOIS A L, et al. Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E.coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model[J]. Gut Microbes, 2021, 13(1):1891852. [19] SUN H H, GONG S Y, CARMODY R J, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis[J]. Cell, 2008, 133(3):415-426. [20] ZHANG Y H, YAN H Q, WANG F, et al. TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation[J]. Int J Oncol, 2015, 46(1):254-264. [21] YANG X L, LIU K Y, LIN F J, et al. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis[J]. Oncol Rep, 2017, 38(3):1393-1401. [22] BADI Y E, SALCMAN B, TAYLOR A, et al. IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma[J]. Allergy, 2023, 78(1):156-167. [23] DE FILIPPO K, DUDECK A, HASENBERG M, et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation[J]. Blood, 2013, 121(24):4930-4937. [24] ZAISS D M W, GAUSE W C, OSBORNE L C, et al. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair[J]. Immunity, 2015, 42(2):216-226. [25] LIU Q, PENG Z M, ZHOU L, et al. Short-chain fatty acid decreases the expression of CEBPB to inhibit miR-145-mediated DUSP6 and thus further suppresses intestinal inflammation[J]. Inflammation, 2022, 45(1):372-386. [26] ZHANG Y C, TAN P, ZHAO Y, et al. Enterotoxigenic Escherichia coli:intestinal pathogenesis mechanisms and colonization resistance by gut microbiota[J]. Gut Microbes, 2022, 14(1):2055943. [27] SHI N, LI N, DUAN X W, et al. Interaction between the gut microbiome and mucosal immune system[J]. Military Med Res, 2017, 4(1):14. [28] SHIN N R, WHON T W, BAE J W. Proteobacteria:microbial signature of dysbiosis in gut microbiota[J]. Trends Biotechnol, 2015, 33(9):496-503. [29] MIRPURI J, RAETZ M, STURGE C R, et al. Proteobacteria-specific IgA regulates maturation of the intestinal microbiota[J]. Gut Microbes, 2014, 5(1):28-39. [30] JIANG D J, KANG A, YAO W F, et al. Euphorbia kansui fry-baked with vinegar modulates gut microbiota and reduces intestinal toxicity in rats[J]. J Ethnopharmacol, 2018, 226:26-35. [31] CANI P D, BIBILONI R, KNAUF C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice[J]. Diabetes, 2008, 57(6):1470-1481. [32] SCHNUPF P, SANSONETTI P J. Shigella pathogenesis:new insights through advanced methodologies[J]. Microbiol Spectr, 2019, 7(2):28. [33] LIU G Y, PILLA G, TANG C M. Shigella host:pathogen interactions:keeping bacteria in the loop[J]. Cell Microbiol, 2019, 21(11):e13062. [34] YANG J C, JACOBS J P, HWANG M, et al. Biotin deficiency induces intestinal dysbiosis associated with an inflammatory bowel disease-like phenotype[J]. Nutrients, 2023, 15(2):264. [35] KUROISHI T. Regulation of immunological and inflammatory functions by biotin[J]. Can J Physiol Pharmacol, 2015, 93(12):1091-1096. [36] SHAN J, OSHIMA T, FUKUI H, et al. Acidic deoxycholic acid and chenodeoxycholic acid induce interleukin-8 production through p38 mitogen-activated protein kinase and protein kinase A in a squamous epithelial model[J]. J Gastroenterol Hepatol, 2013, 28(5):823-828. [37] TICHO A L, MALHOTRA P, DUDEJA P K, et al. Intestinal absorption of bile acids in health and disease[J]. Compr Physiol, 2019, 10(1):21-56. [38] IZADPARAST F, RIAHI-ZAJANI B, YARMOHAMMADI F, et al. Protective effect of berberine against LPS-induced injury in the intestine:a review[J]. Cell Cycle, 2022, 21(22):2365-2378. [39] ROSKOSKI R Jr. ERK1/2 MAP kinases:structure, function, and regulation[J]. Pharmacol Res, 2012, 66(2):105-143. [40] ZHENG S H, XUE T Y, WANG B, et al. Chinese medicine in the treatment of ulcerative colitis:the mechanisms of signaling pathway regulations[J]. Am J Chin Med, 2022, 50(7):1781-1798. |